DOCSLIB.ORG

Cholecystokinin, Acting Through the a Receptor Subtype, Stimulates the Proliferative Activity of Adrenocortical Cells and Thymocytes in the Rat

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cholecystokinin, Acting Through the a Receptor Subtype, Stimulates the Proliferative Activity of Adrenocortical Cells and Thymocytes in the Rat Histol Histopathol (1999) 14: 439-443 Histology and 001: 10.14670/HH-14.439 Histopathology http://www.hh.um.es From Cell Biology to Tissue Engineering Cholecystokinin, acting through the A receptor subtype, stimulates the proliferative activity of adrenocortical cells and thymocytes in the rat L.K. Malendowiczl, M. Tretjer1, R. de Caro2, N. Jedrzejczakl, R. Brelinskal, A. Markowskal, G.G. Nussdorfer2 and M. Nowak1 1 Department of Histology and Embryology, School of Medicine, Poznan, Poland and 20 epartment of Anatomy, University of Padua, Padua, Italy Summary. Cholecystokinin (CCK) is a multifunctional gut, and subsequently localized in the central nervous regulatory peptide, which acts through two main system and several peripheral organs and tissues. CCK subtypes of receptors, named CCK-A and CCK-B. acts through two main subtypes of receptors, named Evidence indicates that CCK modulates cell proliferation CCK-A and CCK-B, which belong to the G protein­ in various tissues in a paracrine manner, and proofs are coupled receptor superfamily, and which are ava ilable of the presence of CCK in both adrenal glands predominantly located in th e periphery and central and thymus. Hence, we have investigated the possible nervous system, respectively (for review, see Crawley mitogenic action of this peptide on these two tissues, by and Corwin, 1994). CCK, in addition to controlling evaluating the %0 of metaphase-arrested cells after digestion and exerting many behavioral actions, also vincristin injection (mitotic index). The systemic appears to regulate in a paracrine/autocrine manner cell administration of CCK (three subcutaneous injections of proliferation in several normal and tumorous ti ssue s 20 nmol/ kg, 28, 16 and 4 h before the sacrifice) (Crawley and Corwin, 1994; Forguet-Lafitte et al., ] 996; increased the mitotic index in both the outer adrenal and Nagata et al. , 1996; Xu et al., 1996; Todisco et al., thymus cortexes of immature (20-day-old) rats and the 1997). enucleated adrenal gland of adult (2-month-old) animals Evidence indicates that CCK and its receptors are at day 5 and 8 of regeneration . The simultaneous contained in the adrenal glands. CCK-immunoreactivity administration of equimolar doses of a selective CCK-A is present in some substance P-positive nerve fibers of receptor antagonist blocked the effect of CCK, while a the human and guinea-pig adrenals (Heym et al., CCK-B antagonist was in effective. These findings 1995a,b; Heym, 1997), as well as in epinephrine­ indicate that CCK exerts a marked CCK-A-mediated containing cell of the chicken interrenals (Ohmori et al., proliferogenic effect on both adrenal cortex and thymus 1997). Proof is available that cat adrenal medulla in the rat, the physiological relevance of which, (Gaumann and Yaksh, 1988a,b) and human pheo­ however, remains to be demonstrated . In fact, the chromocytomas (Bard ram et aI., 1989) are able to administration of the CCK-J\ antagonist alone was synthesize CCK, and cultured bovine adrenomedullary ineffective, thereby casting doubts on the role played by cells are provided with CCK-A receptors (Aarnisalo et endogenous CCK in the maintenance and stimulation of al. , 1996). Likewise, CCK and its receptors are prese nt adrenal and thymus growth. in the lymphoid tissue, including thymus (Felten et al., 1985; Weinberg et al., 1997). Key words: Cholecystokinin, Cholecystokinin Therefore, it seemed worthwhile to investigate receptors, Cell proliferation, Adrenal cortex, Thymus, whether CCK is able to modulate adrenocortical-cell and Rat thymocyte proliferation in th e rat. Since the mitotic rate in aclrenals and thymus of adult animals is very low or negligible, we used immature rats or animals bearing Introduction enucleated-regenerating adrenals. Cholecystokinin (CCK) is a 33-amino acid Materials and methods regulatory peptide originally discovered in the porcine Animals and reagents Offprint requests to: Prof. Gastone G. Nussdorfer, Department of Anatomy. Via Gabelli 65.1·35121 Padova, Italy. Fax: (+39) 498272319. Adult (2-month-old) female Wistar rats and their e·mail: [email protected] offspring (20-clay-old) were kept under a 12: 12 h light- Effect of cholecystokinin on adrenals and thymus dark cycle (illumination onset at 8:00 a.m.) at 2321 "C, Bouin's solution for 24 h, embedded in paraffin and and maintained on a standard diet and tap water ad sectioned at 5-6 pm; sections were stained with libiturn. CCK (octapeptide sulfated) was purchased from hematoxylin and eosin. The mitotic index (%o of Bachem (Bubendorf, Switzerland), and the selective metaphase-arrested cells) was calculated at x400, by CCK-A and CCK-B receptor antagonists PD 140,548 counting 5,000 cells in the subcapsular zone of each and PD 135,158, respectively (Hughes et al., 1990; thymus (4-5 layers of cells) or adrenal cortex (7-9 layers Higginbottom et al., 1993) were from Research of cells), and in the regenerating adrenal parenchyma. Biochemicals International (Natick, MA, USA). Vincristin was obtained from Gedeon-Richter (Budapest, Statistical analysis Hungary). Individual results were averaged per experimental Experimental procedures group, and SEM was calculated. The statistical comparison of the data was done by ANOVA, followed Under ether anaesthesia, the left adrenal gland of by the Multiple Range Test of Duncan. adult rats was enucleated, and the controlateral gland removed. Operated rats were given 0.9% NaCl to drink, and were killed 5 or 8 days after surgery. Groups of adult Results rats with adrenal regeneration and immature animals (n = 6) were given three subcutaneous injections (28, 16 CCK increased metaphase index by about 77% and and 4 h before the sacrifice) of the following chemicals 80% in the thymus cortex and adrenal subcapsular layers dissolved in 0.2 m1 0.9% NaCl: (i) CCK (20 nmolkg); of immature rats (Fig. 1). As expected, the mitotic (ii) CCK-A or CCK-B receptor antagonist (20 nmollkg); activity was higher at day 5 of adrenal regeneration than and (iii) CCK plus CCK-A or CCK-B receptor at day 8, and CCK significantly enhanced it at both antagonist. Control rats were injected with saline experimental times (by about 66% and 196%, vehicle. All groups of animals received an intra- respectively) (Fig. 2). The simultaneous administration peritonea1 injection of vincristin (0.1 mg/100 g) 180 min of the CCK-A antagonist annulled the effects of CCK, before the autopsy. Rats were decapitated at 11:OO a.m. while the CCK-B antagonist was ineffective. The administration of either CCK-A or CCK-B antagonists Cell-proliferationassay alone did not significantly alter basal mitotic index of all tissues examined (Figs. 1,2). Thymuses were promptly removed from immature rats, and capsule-adjacent fragments were fixed in 2.5% Discussion glutaraldehyde, postfixed in 1% osmium tetroxide, and embedded in Araldite; 0.5 pm-thick sections were cut, Our present results provide clear-cut evidence that and stained with toluidine blue. Adrenal glands from CCK administration markedly enhances the mitotic immature rats and regenerating adrenals were fixed in metaphase index (l) melaphase index (l) 1 30- 0 controls 25 A @cJ CCK-B antagonist 20- 15- + + 10- Fig. 2. Effects of CCK and CCK-receptor antagonists on adrenocorlical- Flg. 1. Effects of CCK and CCK-receptor antagonists on thymocyte (left cell proliferation at day 5 (left panel) and day 8 (right panel) of rat panel) and adrenocortical-cell (right panel) proliferation in immature rats adrenal regeneration after enucleation (meanskSEM; n = 6). *: p<0.01 (meanskSEM; n = 6). *: p<0.01 from the respective basal (B) value; from the respective basal (B) value; A: p<0.01 from the respective A: p-zO.01 from the respective control group. control group. Effect of cholecystokinin on adrenals and thymus index in both adrenal and thymus, thereby confirming et al., 1990; Molchanova et al., 1992). Our present the involvement of this peptide in the control of cell findings are in keeping with this contention. In fact, proliferation (see Introduction). They also indicate that CCK-A receptor activation by CCK markedly enhances this effect of CCK is mediated by the peripheral type thymocyte proliferation, 25% of which takes place in the CCK-A receptors, because it is annulled by the CCK-A thymus cortex, and especially in the subcapsular zone, receptor antagonist, and unaffected by the CCK-B which is considered the region where thymopoiesis receptor antagonist. The possibility of a non-specific initiates (Scollay and Shortman, 1985; Boyd and Hugo, toxic effect of the CCK-A receptor antagonist is ruled 1991; Scollay and Godfrey, 1995). Although CCK and out by the demonstration that this chemical per se does its receptors are both present in the thymus (see not alter basal mitotic rate. However, our study cast Introduction), in vitro studies did not reveal any effect of doubts that CCK, although contained in both adrenal and this peptide or pentagastrin (a CCK-A receptor agonist) thymus (see Introduction), acts on them in a paracrinet on the mitotic activity of cultured human thymocytes, autocrine manner, as has been suggested to occur in guinea-pig T lymphocytes and rat B lymphocytes (Soder other tissues (Xu et al., 1996; Todisco et al., 1997; and and Hellstrom, 1987), thereby making unlikely the for review, Crawley and Corvin, 1994). possibility of a direct action of CCK on thymus. At It is current knowledge that adrenal growth in present, only tentative hypotheses can be advanced to immature animals and adrenal regeneration after explain the indirect mechanism whereby CCK stimulates enucleation are processes strictly dependent on the thymus growth. There is proof that glucocorticoids, in pituitary ACTH release (for review, see Nussdorfer, addition to enhancing lymphocytolysis, are also 1986), and compelling evidence indicates that CCK is necessary for the intrathymic thymocyte survival and able to activate the entire hypothalamo-pituitary-adrenal differentiation in young animals (Compton et al., 1987; (HPA) axis.
Load more

Recommended publications
  • Strategies to Increase ß-Cell Mass Expansion
    This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Strategies to increase -cell mass expansion Drynda, Robert Lech Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Strategies to increase β-cell mass expansion A thesis submitted by Robert Drynda For the degree of Doctor of Philosophy from King’s College London Diabetes Research Group Division of Diabetes & Nutritional Sciences Faculty of Life Sciences & Medicine King’s College London 2017 Table of contents Table of contents .................................................................................................
    [Show full text]
  • The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands
    The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands Clare Louise Wishart Submitted in accordance with the requirements for the degree of Doctor of Philosophy of Science University of Leeds School of Biomedical Sciences Faculty of Biological Sciences September 2013 I Intellectual Property and Publication Statements The candidate confirms that the work submitted is her own and that appropriate credit has been given where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Clare Louise Wishart to be identified as Author of this work has been asserted by her in accordance with the Copyright, Designs and Patents Act 1988. © 2013 The University of Leeds and Clare Louise Wishart. II Acknowledgments Firstly I would like to offer my sincerest thanks and gratitude to my supervisor, Dr. Dan Donnelly, who has been nothing but encouraging and engaging from day one. I have thoroughly enjoyed every moment of working alongside him and learning from his guidance and wisdom. My thanks go to my academic assessor Professor Paul Milner whom I have known for several years, and during my time at the University of Leeds he has offered me invaluable advice and inspiration. Additionally I would like to thank my academic project advisor Dr. Michael Harrison for his friendship, help and advice. I would like to thank Dr. Rosalind Mann and Dr. Elsayed Nasr for welcoming me into the lab as a new PhD student and sharing their experimental techniques with me, these techniques have helped me no end in my time as a research student.
    [Show full text]
  • Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells
    Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. M Schalling, … , T Hökfelt, J F Rehfeld J Clin Invest. 1990;86(2):660-669. https://doi.org/10.1172/JCI114758. Research Article In previous studies we have shown that the gene encoding cholecystokinin (CCK) is expressed in spermatogenic cells of several mammalian species. In the present study we show that a gene homologous to the CCK-related hormone, gastrin, is expressed in the human testis. The mRNA hybridizing to a human gastrin cDNA probe in the human testis was of the same size (0.7 kb) as gastrin mRNA in the human antrum. By in situ hybridization the gastrinlike mRNA was localized to seminiferous tubules. Immunocytochemical staining of human testis revealed gastrinlike peptides in the seminiferous tubules primarily at a position corresponding to spermatids and spermatozoa. In ejaculated spermatozoa gastrinlike immunoreactivity was localized to the acrosome. Acrosomal localization could also be shown in spermatids with electron microscopy. Extracts of the human testis contained significant amounts of progastrin, but no bioactive amidated gastrins. In contrast, ejaculated sperm contained mature carboxyamidated gastrin 34 and gastrin 17. The concentration of gastrin in ejaculated human spermatozoa varied considerably between individuals. We suggest that amidated gastrin (in humans) and CCK (in other mammals) are released during the acrosome reaction and that they may be important for fertilization. Find the latest version: https://jci.me/114758/pdf Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells Martin Schalling,* Hhkan Persson,t Markku Pelto-Huikko,*9 Lars Odum,1I Peter Ekman,I Christer Gottlieb,** Tomas Hokfelt,* and Jens F.
    [Show full text]
  • Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J
    The Open Nutrition Journal, 2009, 3, 5-7 5 Open Access Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J. Tomasik*, Krystyna Sztefko and Zdzislaw Szafran Department of Clinical Biochemistry, University Children`s Hospital, Krakow, Poland Abstract: Background: It is known that the low ambient temperature causes a considerable increase of appetite. The mechanisms underlying the changes of the amounts of the ingested food in relation to the environmental temperature has not been elucidated. The aim of this study was to investigate the effect of the short exposure to low ambient temperature on the plasma concentration of leptin and cholecystokinin. Methods: Sixteen healthy men, mean age 24.6 ± 3.5 years, BMI 22.3 ± 2.3 kg/m2, participated in the study. The concen- trations of plasma CCK and leptin were determined twice – before and after the 30 min. exposure to + 4 °C by using RIA kits. Results: The mean value of CCK concentration before the exposure to low ambient temperature was 1.1 pmol/l, and after the exposure 0.6 pmol/l (p<0.0005 in the paired t-test). The mean values of leptin before exposure (4.7 ± 1.54 μg/l) were also significantly lower than after the exposure (6.4 ± 1.7 μg/l; p<0.0005 in the paired t-test). However no significant cor- relation was found between CCK and leptin concentrations, both before and after exposure to low temperature. Conclusions: It has been known that a fall in the concentration of CCK elicits hunger and causes an increase in feeding activity.
    [Show full text]
  • Identification of Neuropeptide Receptors Expressed By
    RESEARCH ARTICLE Identification of Neuropeptide Receptors Expressed by Melanin-Concentrating Hormone Neurons Gregory S. Parks,1,2 Lien Wang,1 Zhiwei Wang,1 and Olivier Civelli1,2,3* 1Department of Pharmacology, University of California Irvine, Irvine, California 92697 2Department of Developmental and Cell Biology, University of California Irvine, Irvine, California 92697 3Department of Pharmaceutical Sciences, University of California Irvine, Irvine, California 92697 ABSTRACT the MCH system or demonstrated high expression lev- Melanin-concentrating hormone (MCH) is a 19-amino- els in the LH and ZI, were tested to determine whether acid cyclic neuropeptide that acts in rodents via the they are expressed by MCH neurons. Overall, 11 neuro- MCH receptor 1 (MCHR1) to regulate a wide variety of peptide receptors were found to exhibit significant physiological functions. MCH is produced by a distinct colocalization with MCH neurons: nociceptin/orphanin population of neurons located in the lateral hypothala- FQ opioid receptor (NOP), MCHR1, both orexin recep- mus (LH) and zona incerta (ZI), but MCHR1 mRNA is tors (ORX), somatostatin receptors 1 and 2 (SSTR1, widely expressed throughout the brain. The physiologi- SSTR2), kisspeptin recepotor (KissR1), neurotensin cal responses and behaviors regulated by the MCH sys- receptor 1 (NTSR1), neuropeptide S receptor (NPSR), tem have been investigated, but less is known about cholecystokinin receptor A (CCKAR), and the j-opioid how MCH neurons are regulated. The effects of most receptor (KOR). Among these receptors, six have never classical neurotransmitters on MCH neurons have been before been linked to the MCH system. Surprisingly, studied, but those of most neuropeptides are poorly several receptors thought to regulate MCH neurons dis- understood.
    [Show full text]
  • A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function
    The Journal of Neuroscience, July 15, 2000, 20(14):5564–5573 A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function Seema Bhatnagar,2 Victor Viau,1 Alan Chu,1 Liza Soriano,1 Onno C. Meijer,1 and Mary F. Dallman1 1Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444, and 2Department of Psychology, University of Michigan, Ann Arbor, Michigan 48109 Chronic stress alters hypothalamic-pituitary-adrenal (HPA) re- ceptor antagonist PD 135,158 into the PVTh before restraint in sponses to acute, novel stress. After acute restraint, the posterior control and chronically cold-stressed rats. ACTH responses to division of the paraventricular thalamic nucleus (pPVTh) exhibits restraint stress were augmented by PD 135,158 only in chroni- increased numbers of Fos-expressing neurons in chronically cally stressed rats but not in controls. In addition, CCK-B recep- cold-stressed rats compared with stress-naı¨vecontrols. Further- tor mRNA expression in the pPVTh was not altered by chronic more, lesions of the PVTh augment HPA activity in response to cold stress. We conclude that previous chronic stress specifically novel restraint only in previously stressed rats, suggesting that facilitates the release of CCK into the pPVTh in response to the PVTh is inhibitory to HPA activity but that inhibition occurs acute, novel stress. The CCK is probably secreted from neurons only in chronically stressed rats. In this study, we further exam- in the lateral parabrachial, the periaqueductal gray, and/or the ined pPVTh functions in chronically stressed rats.
    [Show full text]
  • What Is Pancreatic Polypeptide and What Does It Do?
    What is Pancreatic Polypeptide and what does it do? This document aims to evaluate current understanding of pancreatic polypeptide (PP), a gut hormone with several functions contributing towards the maintenance of energy balance. Successful regulation of energy homeostasis requires sophisticated bidirectional communication between the gastrointestinal tract and central nervous system (CNS; Williams et al. 2000). The coordinated release of numerous gastrointestinal hormones promotes optimal digestion and nutrient absorption (Chaudhri et al., 2008) whilst modulating appetite, meal termination, energy expenditure and metabolism (Suzuki, Jayasena & Bloom, 2011). The Discovery of a Peptide Kimmel et al. (1968) discovered PP whilst purifying insulin from chicken pancreas (Adrian et al., 1976). Subsequent to extraction of avian pancreatic polypeptide (aPP), mammalian homologues bovine (bPP), porcine (pPP), ovine (oPP) and human (hPP), were isolated by Lin and Chance (Kimmel, Hayden & Pollock, 1975). Following extensive observation, various features of this novel peptide witnessed its eventual classification as a hormone (Schwartz, 1983). Molecular Structure PP is a member of the NPY family including neuropeptide Y (NPY) and peptide YY (PYY; Holzer, Reichmann & Farzi, 2012). These biologically active peptides are characterized by a single chain of 36-amino acids and exhibit the same ‘PP-fold’ structure; a hair-pin U-shaped molecule (Suzuki et al., 2011). PP has a molecular weight of 4,240 Da and an isoelectric point between pH6 and 7 (Kimmel et al., 1975), thus carries no electrical charge at neutral pH. Synthesis Like many peptide hormones, PP is derived from a larger precursor of 10,432 Da (Leiter, Keutmann & Goodman, 1984). Isolation of a cDNA construct, synthesized from hPP mRNA, proposed that this precursor, pre-propancreatic polypeptide, comprised 95 residues (Boel et al., 1984) and is processed to produce three products (Leiter et al., 1985); PP, an icosapeptide containing 20-amino acids and a signal peptide (Boel et al., 1984).
    [Show full text]
  • The Gastrointestinal Cholecystokinin Receptors in Health and Diseases
    Roczniki Akademii Medycznej w Białymstoku · Vol. 50, 2005 · TheAnnales gastrointestinal Academiae cholecystokinin Medicae Bialostocensis receptors in health and diseases 21 The gastrointestinal cholecystokinin receptors in health and diseases Morisset J* Service de Gastroentérologie, Université de Sherbrooke, Canada Key words: cholecystokinin, gastrin, cholecystokinin recep- gene in different species, their localization and the results of tors, pancreas. their specific occupation under normal and pathological states. Introduction Cholecystokinin Over the years, cholecystokinin (CCK) has been accepted as A. Molecular forms the gastrointestinal hormone mainly responsible for the control Shortly after his discovery of CCK-33 in pig intestine [1], of gallbladder contraction, pancreatic enzyme secretion, growth Mutt purified the slightly larger form CCK-39 from the same of the pancreatic gland and gut motility. On the contrary, its sis- species’ intestine [5]. Later on, smaller and larger molecules ter hormone gastrin is recognized to regulate gastric acid secre- were isolated from several species’ brain and intestine. CCK-58, tion and proliferation of the acid secreting portion of the gastric 8, 5 and 4 were found in porcine brain [6] whereas the molecular mucosae as well as that of the upper intestine and colon. forms 58, 39, 33, 25, 18, 8, 7 and 5 were all identified in dog These two hormones share the same carboxy-terminal pen- intestine [7,8]. Some of these same peptides were also identified tapeptide amide sequence but differ in their sulfation sites on in bovine intestine, 39 and 33, in rat intestine, 58, 22, 8 and in the active C-terminal portion of their molecule; indeed, gastrin guinea pig intestine, 22 and 8 [9-11].
    [Show full text]
  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
    Molecular Pharmacology Fast Forward. Published on June 2, 2020 as DOI: 10.1124/mol.120.119388 This article has not been copyedited and formatted. The final version may differ from this version. File name: Opioid peptides v45 Date: 5/28/20 Review for Mol Pharm Special Issue celebrating 50 years of INRC Five decades of research on opioid peptides: Current knowledge and unanswered questions Lloyd D. Fricker1, Elyssa B. Margolis2, Ivone Gomes3, Lakshmi A. Devi3 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; E-mail: [email protected] 2Department of Neurology, UCSF Weill Institute for Neurosciences, 675 Nelson Rising Lane, San Francisco, CA 94143, USA; E-mail: [email protected] 3Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Annenberg Downloaded from Building, One Gustave L. Levy Place, New York, NY 10029, USA; E-mail: [email protected] Running Title: Opioid peptides molpharm.aspetjournals.org Contact info for corresponding author(s): Lloyd Fricker, Ph.D. Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Ave Bronx, NY 10461 Office: 718-430-4225 FAX: 718-430-8922 at ASPET Journals on October 1, 2021 Email: [email protected] Footnotes: The writing of the manuscript was funded in part by NIH grants DA008863 and NS026880 (to LAD) and AA026609 (to EBM). List of nonstandard abbreviations: ACTH Adrenocorticotrophic hormone AgRP Agouti-related peptide (AgRP) α-MSH Alpha-melanocyte stimulating hormone CART Cocaine- and amphetamine-regulated transcript CLIP Corticotropin-like intermediate lobe peptide DAMGO D-Ala2, N-MePhe4, Gly-ol]-enkephalin DOR Delta opioid receptor DPDPE [D-Pen2,D- Pen5]-enkephalin KOR Kappa opioid receptor MOR Mu opioid receptor PDYN Prodynorphin PENK Proenkephalin PET Positron-emission tomography PNOC Pronociceptin POMC Proopiomelanocortin 1 Molecular Pharmacology Fast Forward.
    [Show full text]
  • Hormonal Influence on Insulin Transport Through the Blood-Brain
    Hormonal influence on insulin transport through the blood- brain barrier and hypothalamic inflammation A dissertation submitted to the Graduate School of the University of Cincinnati In partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY In the Graduate Program of Pathobiology and Molecular Medicine of the College of Medicine December 2016 By Aaron A. May B.S. Agricultural Biochemistry, Iowa State University, Ames, IA Committee chair: Min Liu, PhD. ABSTRACT Insulin is an important effector of energy balance, and it reduces food intake and body weight via its actions in the hypothalamus. Because little or no insulin is produced by the brain, the majority of insulin’s effects in the central nervous system (CNS) are dependent on the transport of insulin through the blood-brain barrier (BBB). My research tests the hypothesis that some of the hormones involved in maintaining energy homeostasis exert their effects by influencing the transport of insulin into the CNS. Specifically, we examined the intestinal hormone, cholecystokinin (CCK), and the gonadal hormone, estrogen, due to their common catabolic actions and their pronounced interactions with central insulin. After observing that CCK receptors and estrogen receptors are both co-expressed with insulin receptors in endothelial cells of the BBB, we found that CCK, but not estrogen (E2), increased the transport of insulin into the CNS. These findings spawned an additional investigation into how E2 mediates its interaction with insulin signaling in the hypothalamus. Although insulin signaling was not increased by E2, we observed a significant reduction of inflammatory signaling in the hypothalamus of these E2-treated rats.
    [Show full text]
  • REVIEW the Role of Rfamide Peptides in Feeding
    3 REVIEW The role of RFamide peptides in feeding David A Bechtold and Simon M Luckman Faculty of Life Sciences, University of Manchester, 1.124 Stopford Building, Oxford Road, Manchester M13 9PT, UK (Requests for offprints should be addressed to D A Bechtold; Email: [email protected]) Abstract In the three decades since FMRFamide was isolated from the evolution. Even so, questions remain as to whether feeding- clam Macrocallista nimbosa, the list of RFamide peptides has related actions represent a primary function of the RFamides, been steadily growing. These peptides occur widely across the especially within mammals. However, as we will discuss here, animal kingdom, including five groups of RFamide peptides the study of RFamide function is rapidly expanding and with identified in mammals. Although there is tremendous it so is our understanding of how these peptides can influence diversity in structure and biological activity in the RFamides, food intake directly as well as related aspects of feeding the involvement of these peptides in the regulation of energy behaviour and energy expenditure. balance and feeding behaviour appears consistently through Journal of Endocrinology (2007) 192, 3–15 Introduction co-localised with classical neurotransmitters, including acetyl- choline, serotonin and gamma-amino bulyric acid (GABA). The first recognised member of the RFamide neuropeptide Although a role for RFamides in feeding behaviour was family was the cardioexcitatory peptide, FMRFamide, first suggested over 20 years ago, when FMRFamide was isolated from ganglia of the clam Macrocallista nimbosa (Price shown to be anorexigenic in mice (Kavaliers et al. 1985), the & Greenberg 1977). Since then a large number of these question of whether regulating food intake represents a peptides, defined by their carboxy-terminal arginine (R) and primary function of RFamide signalling remains.
    [Show full text]
  • Thesis (PDF, 12.23MB)
    Maladaptive changes to Cholecystokinergic systems in the Periaqueductal grey in rats experiencing persistent behavioural disability in the wake of Neuropathic pain Manuel Alfonso Argueta Dominguez A thesis submitted in fulfillment of the requirements for the degree of Master of Philosophy Faculty of Medicine Discipline of Anatomy & Histology The University of Sydney Aug 2020 2 Thesis statement of Originality This is to certify that, to the best of my knowledge, the body of work contained in this thesis is my own work. This thesis has not been submitted for any other degree or purposes. 3 Abstract In 2018, it was estimated that 3.24 million Australians were living with chronic pain, with the total estimated cost to the economy of $73.2 billion (Painaustralia, 2019). People with chronic neuropathic pain report substantial reductions in their quality of life, with disturbances to social relations; alterations to sleep, appetite, metabolic endocrine and sexual dysfunction; a loss of interest in external events; and moderate to severe depression. More often, it is these disabilities rather than the sensory disturbances of allodynia, hyperalgesia, and spontaneous pain, which are deemed by sufferers to be the most debilitating. The neural adaptations underlying the sensory changes of neuropathic pain have been studied in rats and, using a sciatic chronic constriction injury (CCI) model, in combination with resident-intruder behavioural testing, it has been elucidated that a subgroup of animals undergoes complex behavioural and physiological dysfunction despite all animals experiencing similar levels of pain (Kilburn-Watt et al., 2010, Monassi et al., 2003, Mor et al., 2011). The general aim of this thesis is to further characterise the complex behavioural and physiological disturbances (i.e.
    [Show full text]